
JIUZHITANG CO.,LTD — Investor Relations & Filings
JIUZHITANG CO.,LTD. is a pharmaceutical enterprise specializing in the research, development, manufacturing, and distribution of Traditional Chinese Medicine (TCM). Established in 1650, the company is recognized as a time-honored brand with a heritage spanning over three centuries. Its core product portfolio includes a diverse range of TCM formulations, most notably Liuwei Dihuang Wan, donkey-hide gelatin (Ejiao), and various health supplements focused on chronic disease management and general wellness. The company operates modern production facilities that integrate traditional processing techniques with contemporary scientific standards and biotechnology. JIUZHITANG focuses on the modernization of TCM through clinical research and innovation, maintaining a distribution network that serves retail pharmacies and medical institutions to provide natural healthcare solutions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于召开2020年第二次临时股东大会的通知 | 2020-06-23 | Chinese | |
| 独立董事候选人声明(孙健) | 2020-06-23 | Chinese | |
| 第七届董事会第二十一次会议决议公告 | 2020-06-23 | Chinese | |
| 关于提名董事候选人以及独立董事辞职的公告 | 2020-06-23 | Chinese | |
| 独立董事关于第七届董事会第二十一次会议的独立意见 | 2020-06-23 | Chinese | |
| 独立董事候选人声明(谢丰) | 2020-06-23 | Chinese |
Browse filings by year
26 years- 2026 27 filings
- 2025 83 filings
- 2024 131 filings
- 2023 65 filings
- 2022 97 filings
- 2021 74 filings
- 2020 122 filings
- 2019 88 filings
- 2018 118 filings
- 2017 117 filings
- 2016 95 filings
- 2015 145 filings
- 2014 96 filings
- 2013 53 filings
- 2012 66 filings
- 2011 58 filings
- 2010 46 filings
- 2009 36 filings
- 2008 66 filings
- 2007 74 filings
- 2006 83 filings
- 2005 37 filings
- 2004 35 filings
- 2003 43 filings
- 2002 23 filings
- 2001 7 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2020
15 filings
| |||||
| 44276338 | 关于召开2020年第二次临时股东大会的通知 | 2020-06-23 | Chinese | ||
| 44276314 | 独立董事候选人声明(孙健) | 2020-06-23 | Chinese | ||
| 44276297 | 第七届董事会第二十一次会议决议公告 | 2020-06-23 | Chinese | ||
| 44276283 | 关于提名董事候选人以及独立董事辞职的公告 | 2020-06-23 | Chinese | ||
| 44276281 | 独立董事关于第七届董事会第二十一次会议的独立意见 | 2020-06-23 | Chinese | ||
| 44276266 | 独立董事候选人声明(谢丰) | 2020-06-23 | Chinese | ||
| 44276250 | 关于控股股东部分股份解除质押的公告 | 2020-06-18 | Chinese | ||
| 44276238 | 关于签署战略合作框架协议的公告 | 2020-06-04 | Chinese | ||
| 44276228 | 容诚会计师事务所(特殊普通合伙)关于对公司的年报问询函的回复 | 2020-06-03 | Chinese | ||
| 44276213 | 中联资产评估集团有限公司《关于对九芝堂股份有限公司的年报问询函》的回复 | 2020-06-03 | Chinese | ||
| 44276173 | 关于对深圳证券交易所2019年年报问询函的回复公告 | 2020-06-03 | Chinese | ||
| 44276134 | 北京市金杜律师事务所关于深圳证券交易所《关于对九芝堂股份有限公司的年报问询函》之专项核查意见 | 2020-06-03 | Chinese | ||
| 44276125 | 第七届董事会第二十次会议决议公告 | 2020-06-02 | Chinese | ||
| 44276112 | 关于聘任公司董事会秘书的公告 | 2020-06-02 | Chinese | ||
| 44276102 | 关于控股股东部分股份解除质押的公告 | 2020-06-02 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
JIUZHITANG CO.,LTD via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/53946/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=53946 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=53946 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=53946 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 53946}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for JIUZHITANG CO.,LTD (id: 53946)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.